⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL14722960 | 0.95 | — | — | |
| Bromide SCHEMBL324722 | 0.95 | — | — | |
| SCHEMBL7203154 | 0.79 | — | — | |
| SCHEMBL11940925 | 0.76 | — | — | |
| SCHEMBL2860312 | 0.76 | — | — | |
| SCHEMBL13476029 | 0.76 | — | — | |
| SCHEMBL10035838 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL10708970 | 0.73 | — | — | |
| SCHEMBL13308377 | 0.71 | — | — | |
| SCHEMBL5803958 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743078-A2 | APOL1 INHIBITORS AND METHODS OF USE | Maze Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743079-A2 | APOL1 INHIBITORS AND METHODS OF USE THEREOF | Maze Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20250361273-A1 | METHODS AND COMPOSITIONS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC | 2025-11-27 | — | — | US | disclosed |
| US-20250092054-A1 | FUSED PYRIDINES FOR CONTROLLING INVERTEBRATE PESTS | FMC CORPORATION | 2025-03-20 | — | — | US | disclosed |
| WO-2025015106-A2 | APOL1 INHIBITORS AND METHODS OF USE THEREOF | MAZE THERAPEUTICS, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| WO-2025015104-A2 | APOL1 INHIBITORS AND METHODS OF USE | MAZE THERAPEUTICS, INC. (US) | 2025-01-16 | — | — | WO | disclosed |
| US-12103915-B2 | TEAD inhibitors and methods of uses thereof | INSILICO MEDICINE IP LIMITED (HK) | 2024-10-01 | — | — | US | disclosed |
| US-20240166608-A1 | TEAD INHIBITORS AND METHODS OF USES THEREOF | INSILICO MEDICINE IP LIMITED (HK) | 2024-05-23 | — | — | US | disclosed |
| EP-4347587-A1 | FUSED PYRIDINES FOR CONTROLLING INVERTEBRATE PESTS | FMC Corporation (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4313295-A1 | PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) | Almac Discovery Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| WO-2007080131-A2 | ANTHRANILAMIDE DERIVATIVES AND THEIR USE FOR THE CONTROL OF INSECTS AND ACARI | SYNGENTA PARTICIPATIONS AG (CH) | 2007-07-19 | — | — | WO | disclosed |
| WO-2007046548-A1 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CANNABINOID RECEPTOR ANTAGONISTS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-04-26 | — | — | WO | disclosed |
| WO-2003054037-A1 | COMPLEXES BASED ON HETERO-CYCLOBUTENYL LIGANDS | EQUISTAR CHEMICALS, LP (US) | 2003-07-03 | — | — | WO | disclosed |
| US-6586545-B1 | Olefin polymerization catalyst, activator and complex of metal and heterocyclobetenyl ligand | EQUISTAR CHEMICALS, LP | 2003-07-01 | — | — | US | disclosed |
| EP-0811012-A1 | METHOD OF PRODUCING L-ASPARTYL-D-ALANINE-N-(THIETHANE-3-YL)-AMIDES | Degussa Aktiengesellschaft (DE) | 1997-12-10 | — | — | EP | disclosed |
| WO-1996026213-A1 | METHOD OF PRODUCING L-ASPARTYL-D-ALANINE-N-(THIETHANE-3-YL)-AMIDES | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1996-08-29 | — | — | WO | disclosed |
| US-5407932-A | Bactericides | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1995-04-18 | — | — | US | disclosed |
| EP-0393400-B1 | Novel quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same | WAKUNAGA SEIYAKU KK (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5245037-A | Synthetic bactericides | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1993-09-14 | — | — | US | disclosed |
| EP-0393400-A1 | Novel quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1990-10-24 | — | — | EP | disclosed |